These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3441287)

  • 21. [Predictive factors of cases secondary to meningococcal infection in Barcelona. Epidemiology of the disease].
    Orcau Palau A; Pañella Noguera H
    Rev Esp Salud Publica; 1998; 72(5):443-9. PubMed ID: 9951341
    [No Abstract]   [Full Text] [Related]  

  • 22. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
    Sexton K; Lennon D; Oster P; Crengle S; Martin D; Mulholland K; Percival T; Reid S; Stewart J; O'Hallahan J
    N Z Med J; 2004 Aug; 117(1200):U1015. PubMed ID: 15475985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious diseases. The role of the specialist health visitor.
    Room R
    Nursing (Lond); 1990 Oct 11-24; 4(20):27-30. PubMed ID: 2243623
    [No Abstract]   [Full Text] [Related]  

  • 26. [Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain].
    Parent du Châtelet I; Taha MK; Sesboüé C; Rouaud P; Perrocheau A; Lévy-Bruhl D
    Arch Pediatr; 2007 Jun; 14(6):537-40. PubMed ID: 17418547
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coverage of meningococcal infections by local health authorities in Seine-Maritime].
    Sesboüé C
    Arch Pediatr; 2007 Jun; 14(6):544-5. PubMed ID: 17391939
    [No Abstract]   [Full Text] [Related]  

  • 28. The strategy to control New Zealand's epidemic of group B meningococcal disease.
    O'Hallahan J; Lennon D; Oster P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S293-8. PubMed ID: 15597072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Getting to grips with an epidemic.
    Desmond N
    Nurs N Z; 2004 Aug; 10(7):2. PubMed ID: 15460638
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.
    Kelly C; Arnold R; Galloway Y; O'Hallahan J
    Am J Epidemiol; 2007 Oct; 166(7):817-23. PubMed ID: 17615088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic overview of meningococcal infections in Texas, 1964-1968.
    Lerro SJ
    Tex Med; 1970 Sep; 66(9):44-51. PubMed ID: 5517287
    [No Abstract]   [Full Text] [Related]  

  • 32. Meningococcal disease: quelling the panic.
    Lynch J
    Can Nurse; 1992 Apr; 88(4):13-4. PubMed ID: 1568187
    [No Abstract]   [Full Text] [Related]  

  • 33. Meningococcal pneumonia.
    Schweon SJ
    RN; 2009 Aug; 72(8):22-5. PubMed ID: 19743586
    [No Abstract]   [Full Text] [Related]  

  • 34. Meningococcal disease among children who live in a large metropolitan area, 1981-1996.
    Wang VJ; Kuppermann N; Malley R; Barnett ED; Meissner HC; Schmidt EV; Fleisher GR
    Clin Infect Dis; 2001 Apr; 32(7):1004-9. PubMed ID: 11264027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of meningococcal disease in South Island, New Zealand.
    Holmes J
    Commun Dis Public Health; 2003 Apr; 6(1):68; author reply 68-9. PubMed ID: 12736978
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal disease: recognition, treatment, and prevention.
    Herf C; Nichols J; Fruh S; Holloway B; Anderson CU
    Nurse Pract; 1998 Aug; 23(8):30, 33-6, 39-40 passim. PubMed ID: 9718600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a theoretical framework in paediatric intensive care to provide support for parents of children with severe meningococcal disease.
    Haines C
    Nurs Crit Care; 2000; 5(2):87-97. PubMed ID: 11143624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognising meningococcal meningitis and septicaemia.
    Glennie L
    Prof Care Mother Child; 1998; 8(6):159-60. PubMed ID: 10197023
    [No Abstract]   [Full Text] [Related]  

  • 39. Social context of meningococcal disease.
    Charlton R
    Lancet; 1998 Oct; 352(9135):1227. PubMed ID: 9777870
    [No Abstract]   [Full Text] [Related]  

  • 40. Presenting features of meningococcal disease, public health messages and media publicity: are they consistent?
    Aponso D; Bullen C
    N Z Med J; 2001 Mar; 114(1127):83-5. PubMed ID: 11297142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.